is supported by a Banting and Best Diabetes Centre Novo Nordisk Chair in Incretin Biology, a Sinai Health-Novo Nordisk Foundation Chair in Regulatory Peptides, CIHR grants 154321 and 192044, and Diabetes Canada-Canadian Cancer Society Grant OG-3-24-5819-DD
GLP-1s mimic natural hormones that regulate hunger and slow digestion
This change in normal digestive rhythm, combined with dietary modifications and activation of GLP-1 receptors in the intestinal lining, can lead to changes in bowel habits including diarrhea in some patients
Document your symptoms Keep a daily symptom diary Record what you can/cannot eat Note severity and frequency of vomiting Track weight changes Photograph any visible symptoms Legal considerations while still on the medication: Advantages of early action: Easier to prove causation clear temporal relationship Testing while symptomatic more likely to show abnormalities Fresh medical records contemporaneous documentation Can show progression symptoms while on drug vs
Well, both Eli Lilly and Novo Nordisk have direct-to-consumer programs at around $500 per month, and theyre being utilized
No improvement in appetite